Testimonials

Quotes from delegates at previous MTI Europe Conferences:

"Both the number of investors and their calibre proved unrivalled in what was a thoroughly enjoyable and productive conference."
Sameer Kothari, Chief Executive, Zilico Ltd, UK

"We found the event very valuable and were very impressed with the calibre of the entrepreneurs and the good turn out from corporates and VCs too. A massive thank you from us!"
Hazel Moore, Chairman & Founder, First Capital                          

"The quality of attendees was good. There were many primary investors and you did a good job of keeping the service providers away"
Terry Winters, CEO, Vital Therapies and Partner, Valley Ventures, USA   

"I had the pleasure of attending the 9th MedTech Investment Europe conference. A good level of investors attended the event and what I appreciated was the good balance between the investors and entrepreneurs. This allowed me to arrange a good number of meetings and establish new valuable contacts. Due to the size of this event, it was very good for networking and allowed for some excellent socialising as well. Congratulations for the excellent organisation!"
Alexander Verhees, Chief Financial Officer, Advanced Medical Diagnostics "Histoscanning", Belgium         

 "Less is more and a critical mass of interesting investors"
Ylva Hultman Erlandsson, Director, Stockholm Business Region, Sweden

"The recent session in London was terrific - well organized and efficient. It's clear that your meetings are playing an important role during a period when our industry is becoming even more global, and our capital markets are more cross-linked than ever before."
Jay Watkins, Managing Director, De Novo Ventures, USA

 "The MTI Europe conference held in London in October 2009 was very informative, bringing together global experts from a number of key sectors including the multi-national medical device industry, VC & corporate investors, emerging med tech and diagnostic companies. It provided an up-to-date analysis on emerging "hot" technology areas, regulatory and investment trends and key considerations for future technology advancements, partnerships, valuations, acquisition and exit strategies.  It also provided a forum to showcase globally emerging med tech and diagnostic companies and technologies. The interactive round-table discussions translated the business learnings of today into the business opportunities and business strategies of the future. MTI Europe should be on the calendar of SMEs, MNCs, VCs and corporate investors involved in medical devices and diagnostic companies." 
Daniel O'Mahony, Partner, Seroba Kernel Life Sciences, Ireland                  

"This is an excellent Medtech platform for Israeli companies to network with leading European investors and VC exploring investments opportunities.  The program, the round tables and the panels, are a great way to get better understanding of the market conditions and the corporate interest at different fields. This should be a regular fixture for any Israeli company hoping to get involved in Europe."
Nissim Darvish, Partner, Pitango Ventures, Israel

"Thank you all for the excellent MTI Conference. I have now attended five of your meetings, and you should know that I really appreciated already the first meeting I visited. But for me and most other attendees, it is obvious that the event continues to be under constant progress. The conference venues in London have always been very good but I found Kings Fund, where we were this year, to be even better.

But my strongest reason to continue to come back every year is the fact that the most relevant people in the field of European medical technology, attend the meeting. There are experienced people from the investment business and from the global medtech industry and a relatively large number of young European innovative medical companies.                                                             

It is extremely useful for me to be able to come and hear about the policies and strategies within the investment companies and how the larger industries look upon smaller research companies and hear about their strategies for the future. And it is equally important for me to be able to give an update on Biolight and report about our progress. I am sure this will be of great value to us in a longer perspective.

Looking forward to se you all again next year."
Claes Holmberg, CEO, Biolight AB, Sweden